Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
This glow moisturizer locks in hydration while supporting a radiant finish
There are times for regulatory discretion
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)
Here, we further investigated the c-MET/HGF signalling pathway in SCLC with focus on the phosphoproteome
Zepbound's December 2024 FDA approval for obstructive sleep apnea (OSA) opens an entirely new patient population, with tirzepatide now the first approved pharmacotherapy for OSA
